Botulinum toxin injection for hypercontractile or spastic esophageal motility disorders: May high-resolution manometry help to select cases?

Diseases of the Esophagus

Volumn 28, Issue 8, 2015, Pages 735-741

  Marjoux, S ^a   Brochard, C ^d   Roman, S ^a,b,c   Gincul, R ^a   Pagenault, M ^d   Ponchon, T ^a,b,c   Ropert, A ^d   Mion, F ^a,b,c  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c LABTAU   (France)

^d RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

Achalasia; Distal esophageal spasm; Endoscopic treatment; Jackhammer esophagus

Indexed keywords

BOTULINUM TOXIN; ACETYLCHOLINE RELEASE INHIBITOR;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ESOPHAGUS ACHALASIA; ESOPHAGUS FUNCTION DISORDER; ESOPHAGUS MANOMETRY; ESOPHAGUS SPASM; FEMALE; HUMAN; LOWER ESOPHAGUS SPHINCTER; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THORAX PAIN; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; WEIGHT REDUCTION; CLASSIFICATION; ESOPHAGEAL MOTILITY DISORDERS; ESOPHAGOSCOPY; ESOPHAGUS; EVALUATION STUDY; INJECTION; MANOMETRY; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT SELECTION; PREDICTIVE VALUE; PRESSURE; PROCEDURES; SPASTICITY; VERY ELDERLY;

ACETYLCHOLINE RELEASE INHIBITORS; ADULT; AGED; AGED, 80 AND OVER; BOTULINUM TOXINS; ESOPHAGEAL MOTILITY DISORDERS; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; HUMANS; INJECTIONS; MALE; MANOMETRY; MIDDLE AGED; MUSCLE SPASTICITY; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PRESSURE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 85000093601     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/dote.12282     Document Type: Article

References (35)

1. Roman S, Kahrilas P J. Distal esophageal spasm. Dysphagia 2012; 27: 115-123.
2. Ciulla A, Cremona F, Genova G etal. Echo-guided injection of botulinum toxin versus blind endoscopic injection in patients with achalasia: final report. Minerva Gastroenterol Dietol 2013; 59: 237-240.
3. Leconte M, Douard R, Gaudric M etal. Functional results after extended myotomy for diffuse oesophageal spasm. Br J Surg 2007; 94: 1113-1118.
4. Woisard-Bassols V, Alshehri S, Simonetta-Moreau M. The effects of botulinum toxin injections into the cricopharyngeus muscle of patients with cricopharyngeus dysfunction associated with pharyngo-laryngeal weakness. Eur Arch Otorhinolaryngol 2013; 270: 805-815.
5. Pasricha P J, Rai R, Ravich W J etal. Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology 1996; 110: 1410-1415.
6. Shiwaku H, Inoue H, Beppu R etal. Successful treatment of diffuse esophageal spasm by peroral endoscopic myotomy. Gastrointest Endosc 2013; 77: 149-150.
7. Vantrappen G. Being toxic to the oesophagus. Gut 1997; 41: 131-132.
8. Allescher H D, Storr M, Seige M etal. Treatment of achalasia: botulinum toxin injection vs. pneumatic balloon dilation. A prospective study with long-term follow-Up. Endoscopy 2001; 33: 1007-1017.
9. Cuilliere C, Ducrotte P, Zerbib F etal. Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin. Gut 1997; 41: 87-92.
10. Gordon J M, Eaker E Y. Prospective study of esophageal botulinum toxin injection in high-risk achalasia patients. Am J Gastroenterol 1997; 92: 1812-1817.
11. Leyden J E, Moss A C, MacMathuna P. Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia. Cochrane Database Syst Rev 2006(4); CD005046.
12. Fovos A, Jarral O, Patel V etal. Does Heller's myotomy provide superior clinical outcome in comparison to botulinum toxin injection for treatment of achalasia? Best evidence topic (BET). Int J Surg 2012; 10: 120-123.
13. Vaezi M F. Botulinum toxin in non-achalasia motility disorders: a welcomed therapy in an area with limited therapeutic options. Clin Gastroenterol Hepatol 2013; 11: 1122-1124.
14. Miller L S, Parkman H P, Schiano T D etal. Treatment of symptomatic nonachalasia esophageal motor disorders with botulinum toxin injection at the lower esophageal sphincter. Dig Dis Sci 1996; 41: 2025-2031.
15. Storr M, Allescher H D, Rosch T etal. Treatment of symptomatic diffuse esophageal spasm by endoscopic injections of botulinum toxin: a prospective study with long-term follow-up. Gastrointest Endosc 2001; 54: 754-759.
16. Miller L S, Pullela S V, Parkman H P etal. Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal junction. Am J Gastroenterol 2002; 97: 1640-1646.
17. Bashashati M, Andrews C, Ghosh S etal. Botulinum toxin in the treatment of diffuse esophageal spasm. Dis Esophagus 2010; 23: 554-560.
18. Han J P, Hong S J, Kim H I etal. Symptomatic improvement of diffuse esophageal spasm after botulinum toxin injection. Korean J Gastroenterol 2012; 60: 109-112.
19. Vanuytsel T, Bisschops R, Farre R etal. Botulinum toxin reduces dysphagia in patients with non-achalasia primary esophageal motility disorders. Clin Gastroenterol Hepatol 2013; 11: 1115-1121, e2.
20. Bredenoord A J, Fox M, Kahrilas P J etal. Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil 2012; 24 (Suppl. 1): 57-65.
21. Rohof W O, Salvador R, Annese V etal. Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology 2013; 144: 718-725.
22. Pandolfino J E, Kwiatek M A, Nealis T etal. Achalasia: a new clinically relevant classification by high-resolution manometry. Gastroenterology 2008; 135: 1526-1533.
23. Pratap N, Kalapala R, Darisetty S etal. Achalasia cardia subtyping by high-resolution manometry predicts the therapeutic outcome of pneumatic balloon dilatation. J Neurogastroenterol Motil 2011; 17: 48-53.
24. Yamashita H, Ashida K, Fukuchi T etal. Predictive factors associated with the success of pneumatic dilatation in Japanese patients with primary achalasia: a study using high-resolution manometry. Digestion 2013; 87: 23-28.
25. Eckardt V F, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology 1992; 103: 1732-1738.
26. Marjoux S, Roman S, Juget-Pietu F etal. Impaired postoperative EGJ relaxation as a determinant of post laparoscopic fundoplication dysphagia: a study with high-resolution manometry before and after surgery. Surg Endosc 2012; 26: 3642-3649.
27. Daum C, Sweis R, Kaufman E etal. Failure to respond to physiologic challenge characterizes esophageal motility in erosive gastro-esophageal reflux disease. Neurogastroenterol Motil 2011; 23: 517-e200.
28. Ghosh S K, Pandolfino J E, Rice J etal. Impaired deglutitive EGJ relaxation in clinical esophageal manometry: a quantitative analysis of 400 patients and 75 controls. Am J Physiol Gastrointest Liver Physiol 2007; 293: G878-885.
29. Pandolfino J E, Fox M R, Bredenoord A J etal. High-resolution manometry in clinical practice: utilizing pressure topography to classify oesophageal motility abnormalities. Neurogastroenterol Motil 2009; 21: 796-806.
30. Pandolfino J E, Leslie E, Luger D etal. The contractile deceleration point: an important physiologic landmark on oesophageal pressure topography. Neurogastroenterol Motil 2010; 22: 395-400, e90.
31. Marjoux S, Pioche M, Benet T etal. Fatal mediastinitis following botulinum toxin injection for esophageal spasm. Endoscopy 2013; 45: E405-406.
32. Eaker E Y, Gordon J M, Vogel S B. Untoward effects of esophageal botulinum toxin injection in the treatment of achalasia. Dig Dis Sci 1997; 42: 724-727.
33. Mac Iver R, Liptay M, Johnson Y. A case of mediastinitis following botulinum toxin type A treatment for achalasia. Nat Clin Pract Gastroenterol Hepatol 2007; 4: 579-582.
34. Radaelli F, Paggi S, Terreni N etal. Acute reversible gastroparesis and megaduodenum after botulinum toxin injection for achalasia. Gastrointest Endosc 2010; 71: 1326-1327.
35. ASGE Standards Of Practice Committee, Banerjee S, Shen B etal. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc 2008; 67: 791-798.